Skip to main content
Top
Published in: European Journal of Nutrition 2/2017

01-03-2017 | Original Contribution

Metabolic changes in serum metabolome in response to a meal

Authors: Aahana Shrestha, Elisabeth Müllner, Kaisa Poutanen, Hannu Mykkänen, Ali A. Moazzami

Published in: European Journal of Nutrition | Issue 2/2017

Login to get access

Abstract

Purpose

The change in serum metabolic response from fasting state to postprandial state provides novel insights into the impact of a single meal on human metabolism. Therefore, this study explored changes in serum metabolite profile after a single meal.

Methods

Nineteen healthy postmenopausal women with normal glucose tolerance participated in the study. They received a meal consisting of refined wheat bread (50 g carbohydrates, 9 g protein, 4.2 g fat and 2.7 g dietary fibre), 40 g cucumber and 300 mL noncaloric orange drink. Blood samples were collected at fasting and five postprandial time points. Metabolic profile was measured by nuclear magnetic resonance and targeted liquid chromatography–mass spectrometry. Changes over time were assessed with multivariate models and ANOVA, with baseline as control.

Results

The metabolomic analyses demonstrated alterations in phospholipids, amino acids and their breakdown products, glycolytic products, acylcarnitines and ketone bodies after a single meal. More specifically, phosphatidylcholines, lysophosphatidylcholines and citrate displayed an overall declining pattern, while leucine, isoleucine, methionine and succinate increased initially but declined thereafter. A sharp decline in acylcarnitines and ketone bodies and increase in glycolytic products postprandially suggest a switch in the body’s energy source from β-oxidation to glycolysis. Moreover, individuals with relatively high postprandial insulin responses generated a higher postprandial leucine responses compared to participants with lower insulin responses.

Conclusions

The study demonstrated complex changes from catabolic to anabolic metabolism after a meal and indicated that the extent of postprandial responses is different between individuals with high and low insulin response.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Häring HU, Schleicher ED, Xu G, Lehmann R (2009) Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol: Endocrinol Metab 296(2):E384–E393 Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Häring HU, Schleicher ED, Xu G, Lehmann R (2009) Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol: Endocrinol Metab 296(2):E384–E393
2.
go back to reference Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE, Mootha VK (2008) Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 4:214 Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE, Mootha VK (2008) Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 4:214
3.
go back to reference Ho JE, Larson MG, Vasan RS, Ghorbani A, Cheng S, Rhee EP, Florez JC, Clish CB, Gerszten RE, Wang TJ (2013) Metabolite profiles during oral glucose challenge. Diabetes 62(8):2689–2698CrossRef Ho JE, Larson MG, Vasan RS, Ghorbani A, Cheng S, Rhee EP, Florez JC, Clish CB, Gerszten RE, Wang TJ (2013) Metabolite profiles during oral glucose challenge. Diabetes 62(8):2689–2698CrossRef
4.
go back to reference Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O’Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17(4):448–453CrossRef Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O’Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17(4):448–453CrossRef
6.
go back to reference Nicholson JK, Wilson ID (2003) Understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2(8):668–676CrossRef Nicholson JK, Wilson ID (2003) Understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2(8):668–676CrossRef
7.
go back to reference Spégel P, Danielsson APH, Bacos K, Nagorny CLF, Moritz T, Mulder H, Filipsson K (2010) Metabolomic analysis of a human oral glucose tolerance test reveals fatty acids as reliable indicators of regulated metabolism. Metabolomics 6(1):56–66CrossRef Spégel P, Danielsson APH, Bacos K, Nagorny CLF, Moritz T, Mulder H, Filipsson K (2010) Metabolomic analysis of a human oral glucose tolerance test reveals fatty acids as reliable indicators of regulated metabolism. Metabolomics 6(1):56–66CrossRef
8.
go back to reference Node K, Inoue T (2009) Postprandial hyperglycemia as an etiological factor in vascular failure. Cardiovasc Diabetol 8:23CrossRef Node K, Inoue T (2009) Postprandial hyperglycemia as an etiological factor in vascular failure. Cardiovasc Diabetol 8:23CrossRef
9.
go back to reference Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, Anfossi G, Costa G, Trovati M (2006) Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga diabetes study. J Clin Endocrinol Metab 91(3):813–819CrossRef Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, Anfossi G, Costa G, Trovati M (2006) Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga diabetes study. J Clin Endocrinol Metab 91(3):813–819CrossRef
11.
go back to reference Gannon MC, Nuttall FQ, Lane JT, Burmeister LA (1992) Metabolic response to cottage cheese or egg white protein, with or without glucose, in type II diabetic subjects. Metabolism 41(10):1137–1145CrossRef Gannon MC, Nuttall FQ, Lane JT, Burmeister LA (1992) Metabolic response to cottage cheese or egg white protein, with or without glucose, in type II diabetic subjects. Metabolism 41(10):1137–1145CrossRef
12.
go back to reference Nuttall F, Gannon M (2004) Metabolic response of people with type 2 diabetes to a high protein diet. Nutr Metab 1(1):6CrossRef Nuttall F, Gannon M (2004) Metabolic response of people with type 2 diabetes to a high protein diet. Nutr Metab 1(1):6CrossRef
13.
go back to reference Berger S, Vongaraya M (1966) Insulin response to ingested protein in diabetes. Diabetes 15:303–306CrossRef Berger S, Vongaraya M (1966) Insulin response to ingested protein in diabetes. Diabetes 15:303–306CrossRef
14.
go back to reference Van Loon LJC, Kruijshoop M, Menheere PPCA, Wagenmakers AJM, Saris WHM, Keizer HA (2003) Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care 26(3):625–630CrossRef Van Loon LJC, Kruijshoop M, Menheere PPCA, Wagenmakers AJM, Saris WHM, Keizer HA (2003) Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care 26(3):625–630CrossRef
15.
go back to reference Gannon M, Nuttall F, Neil B, Westphal S (1988) The insulin and glucose responses to meals of glucose plus various proteins in type 2 diabetic subjects. Metabolism 37:1081–1088CrossRef Gannon M, Nuttall F, Neil B, Westphal S (1988) The insulin and glucose responses to meals of glucose plus various proteins in type 2 diabetic subjects. Metabolism 37:1081–1088CrossRef
16.
go back to reference Moazzami AA, Shrestha A, Morrison DA, Poutanen K, Mykkänen H (2014) Metabolomics reveals differences in postprandial responses to breads and fasting metabolic characteristics associated with postprandial insulin demand in postmenopausal women. J Nutr 144(6):807–814. doi:10.3945/jn.113.188912 CrossRef Moazzami AA, Shrestha A, Morrison DA, Poutanen K, Mykkänen H (2014) Metabolomics reveals differences in postprandial responses to breads and fasting metabolic characteristics associated with postprandial insulin demand in postmenopausal women. J Nutr 144(6):807–814. doi:10.​3945/​jn.​113.​188912 CrossRef
17.
go back to reference Alberti KGMM, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15(7):539–553CrossRef Alberti KGMM, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15(7):539–553CrossRef
18.
go back to reference Illig T, Gieger C, Zhai G, Römisch-Margl W, Wang-Sattler R, Prehn C, Altmaier E, Kastenmüller G, Kato BS, Mewes HW, Meitinger T, De Angelis MH, Kronenberg F, Soranzo N, Wichmann HE, Spector TD, Adamski J, Suhre K (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42(2):137–141CrossRef Illig T, Gieger C, Zhai G, Römisch-Margl W, Wang-Sattler R, Prehn C, Altmaier E, Kastenmüller G, Kato BS, Mewes HW, Meitinger T, De Angelis MH, Kronenberg F, Soranzo N, Wichmann HE, Spector TD, Adamski J, Suhre K (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42(2):137–141CrossRef
19.
go back to reference Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, Heim K, Campillos M, Holzapfel C, Thorand B, Grallert H, Xu T, Bader E, Huth C, Mittelstrass K, Döring A, Meisinger C, Gieger C, Prehn C, Roemisch-Margl W, Carstensen M, Xie L, Yamanaka-Okumura H, Xing G, Ceglarek U, Thiery J, Giani G, Lickert H, Lin X, Li Y, Boeing H, Joost H-G, de Angelis MH, Rathmann W, Suhre K, Prokisch H, Peters A, Meitinger T, Roden M, Wichmann HE, Pischon T, Adamski J, Illig T (2012) Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. doi:10.1038/msb.2012.43 Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, Heim K, Campillos M, Holzapfel C, Thorand B, Grallert H, Xu T, Bader E, Huth C, Mittelstrass K, Döring A, Meisinger C, Gieger C, Prehn C, Roemisch-Margl W, Carstensen M, Xie L, Yamanaka-Okumura H, Xing G, Ceglarek U, Thiery J, Giani G, Lickert H, Lin X, Li Y, Boeing H, Joost H-G, de Angelis MH, Rathmann W, Suhre K, Prokisch H, Peters A, Meitinger T, Roden M, Wichmann HE, Pischon T, Adamski J, Illig T (2012) Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. doi:10.​1038/​msb.​2012.​43
20.
go back to reference Liebich HM, Forst C (1984) Hydroxycarboxylic and oxocarboxylic acids in urine: products from branched-chain amino acid degradation and from ketogenesis. J Chromatogr: Biomed Appl 309(2):225–242CrossRef Liebich HM, Forst C (1984) Hydroxycarboxylic and oxocarboxylic acids in urine: products from branched-chain amino acid degradation and from ketogenesis. J Chromatogr: Biomed Appl 309(2):225–242CrossRef
21.
go back to reference Foster DW (2012) Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J Clin Investig 122(6):1958–1959CrossRef Foster DW (2012) Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J Clin Investig 122(6):1958–1959CrossRef
22.
go back to reference Vanhove JLK, Zhang W, Kahler SG, Roe CR, Chen YT, Terada N, Chace DH, Iafolla AK, Ding JH, Millington DS (1993) Medium-chain acyl-coa dehydrogenase (Mcad) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet 52(5):958–966 Vanhove JLK, Zhang W, Kahler SG, Roe CR, Chen YT, Terada N, Chace DH, Iafolla AK, Ding JH, Millington DS (1993) Medium-chain acyl-coa dehydrogenase (Mcad) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet 52(5):958–966
23.
go back to reference Krug S, Kastenmüller G, Stückler F, Rist MJ, Skurk T, Sailer M, Raffler J, Römisch-Margl W, Adamski J, Prehn C, Frank T, Engel KH, Hofmann T, Luy B, Zimmermann R, Moritz F, Schmitt-Kopplin P, Krumsiek J, Kremer W, Huber F, Oeh U, Theis FJ, Szymczak W, Hauner H, Suhre K, Daniel H (2012) The dynamic range of the human metabolome revealed by challenges. FASEB J 26(6):2607–2619CrossRef Krug S, Kastenmüller G, Stückler F, Rist MJ, Skurk T, Sailer M, Raffler J, Römisch-Margl W, Adamski J, Prehn C, Frank T, Engel KH, Hofmann T, Luy B, Zimmermann R, Moritz F, Schmitt-Kopplin P, Krumsiek J, Kremer W, Huber F, Oeh U, Theis FJ, Szymczak W, Hauner H, Suhre K, Daniel H (2012) The dynamic range of the human metabolome revealed by challenges. FASEB J 26(6):2607–2619CrossRef
25.
go back to reference Floegel A, Stefan N, Yu Z, Mühlenbruch K, Drogan D, Joost HG, Fritsche A, Häring HU, De Angelis MH, Peters A, Roden M, Prehn C, Wang-Sattler R, Illig T, Schulze MB, Adamski J, Boeing H, Pischon T (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62(2):639–648CrossRef Floegel A, Stefan N, Yu Z, Mühlenbruch K, Drogan D, Joost HG, Fritsche A, Häring HU, De Angelis MH, Peters A, Roden M, Prehn C, Wang-Sattler R, Illig T, Schulze MB, Adamski J, Boeing H, Pischon T (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62(2):639–648CrossRef
27.
go back to reference Ogita K, Ai M, Tanaka A, Ito Y, Hirano T, Yoshino G, Shimokado K (2008) Serum concentration of small dense low-density lipoprotein-cholesterol during oral glucose tolerance test and oral fat tolerance test. Clin Chim Acta 387(1–2):36–41CrossRef Ogita K, Ai M, Tanaka A, Ito Y, Hirano T, Yoshino G, Shimokado K (2008) Serum concentration of small dense low-density lipoprotein-cholesterol during oral glucose tolerance test and oral fat tolerance test. Clin Chim Acta 387(1–2):36–41CrossRef
28.
go back to reference Frayn KN (2002) Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad. Med Princ Pract 11(SUPPL. 2):31–40CrossRef Frayn KN (2002) Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad. Med Princ Pract 11(SUPPL. 2):31–40CrossRef
29.
go back to reference Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Haring H, Schleicher E, Xu G, Lehmann R (2009) Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab 296:E384–E393CrossRef Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Haring H, Schleicher E, Xu G, Lehmann R (2009) Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab 296:E384–E393CrossRef
30.
go back to reference Tai ES, Tan MLS, Stevens RD, Low YL, Muehlbauer MJ, Goh DLM, Ilkayeva OR, Wenner BR, Bain JR, Lee JJM, Lim SC, Khoo CM, Shah SH, Newgard CB (2010) Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 53(4):757–767CrossRef Tai ES, Tan MLS, Stevens RD, Low YL, Muehlbauer MJ, Goh DLM, Ilkayeva OR, Wenner BR, Bain JR, Lee JJM, Lim SC, Khoo CM, Shah SH, Newgard CB (2010) Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 53(4):757–767CrossRef
31.
go back to reference McCormack SE, Shaham O, McCarthy MA, Deik AA, Wang TJ, Gerszten RE, Clish CB, Mootha VK, Grinspoon SK, Fleischman A (2013) Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatric Obes 8(1):52–61. doi:10.1111/j.2047-6310.2012.00087.x CrossRef McCormack SE, Shaham O, McCarthy MA, Deik AA, Wang TJ, Gerszten RE, Clish CB, Mootha VK, Grinspoon SK, Fleischman A (2013) Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatric Obes 8(1):52–61. doi:10.​1111/​j.​2047-6310.​2012.​00087.​x CrossRef
32.
33.
go back to reference Fukagawa NK, Minaker KL, Rowe JW, Goodman MN, Matthews DE, Bier DM, Young VR (1985) Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J Clin Investig 76(6):2306–2311CrossRef Fukagawa NK, Minaker KL, Rowe JW, Goodman MN, Matthews DE, Bier DM, Young VR (1985) Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J Clin Investig 76(6):2306–2311CrossRef
34.
go back to reference Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, Toledo FGS, DeLany JP (2010) Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 18(9):1695–1700. doi:10.1038/oby.2009.510 CrossRef Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, Toledo FGS, DeLany JP (2010) Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 18(9):1695–1700. doi:10.​1038/​oby.​2009.​510 CrossRef
35.
go back to reference Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y (2003) Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52(2):453–462. doi:10.2337/diabetes.52.2.453 CrossRef Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y (2003) Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52(2):453–462. doi:10.​2337/​diabetes.​52.​2.​453 CrossRef
36.
go back to reference Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G (2009) Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res 50(3):574–585. doi:10.1194/jlr.D800028-JLR200 CrossRef Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G (2009) Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res 50(3):574–585. doi:10.​1194/​jlr.​D800028-JLR200 CrossRef
37.
go back to reference Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG (2005) Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54(7):2012–2018CrossRef Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG (2005) Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54(7):2012–2018CrossRef
38.
go back to reference Heimbürger O, Lönnqvist F, Danielsson A, Nordenström J, Stenvinkel P (1997) Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8(9):1423–1430 Heimbürger O, Lönnqvist F, Danielsson A, Nordenström J, Stenvinkel P (1997) Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8(9):1423–1430
39.
go back to reference Pelleymounter MA, Cullen MJ, Healy D, Hecht R, Winters D, McCaleb M (1998) Efficacy of exogenous recombinant murine leptin in lean and obese 10- to 12-mo-old female CD-1 mice. Am J Physiol: Regul Integr Comp Physiol 275(4):R950–R959 Pelleymounter MA, Cullen MJ, Healy D, Hecht R, Winters D, McCaleb M (1998) Efficacy of exogenous recombinant murine leptin in lean and obese 10- to 12-mo-old female CD-1 mice. Am J Physiol: Regul Integr Comp Physiol 275(4):R950–R959
40.
go back to reference Paul Z, Allison H, Margery N, Myrlene S, de Maximilian C, Jason M, Andrew M, John L, Gregory C, George A, Gary D (1996) Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ 313:965–969CrossRef Paul Z, Allison H, Margery N, Myrlene S, de Maximilian C, Jason M, Andrew M, John L, Gregory C, George A, Gary D (1996) Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ 313:965–969CrossRef
41.
go back to reference Zuo H, Shi Z, Yuan B, Dai Y, Wu G, Hussain A (2013) Association between serum leptin concentrations and insulin resistance: a population-based study from China. PLoS ONE 8(1):e54615CrossRef Zuo H, Shi Z, Yuan B, Dai Y, Wu G, Hussain A (2013) Association between serum leptin concentrations and insulin resistance: a population-based study from China. PLoS ONE 8(1):e54615CrossRef
42.
go back to reference Zimmet P, Hodge A, Nicolson M, Staten M, De Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G (1996) Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. Br Med J 313(7063):965–969CrossRef Zimmet P, Hodge A, Nicolson M, Staten M, De Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G (1996) Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. Br Med J 313(7063):965–969CrossRef
Metadata
Title
Metabolic changes in serum metabolome in response to a meal
Authors
Aahana Shrestha
Elisabeth Müllner
Kaisa Poutanen
Hannu Mykkänen
Ali A. Moazzami
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 2/2017
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-015-1111-y

Other articles of this Issue 2/2017

European Journal of Nutrition 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.